Secondary structure alterations in insulin and growth hormone water-in-oil emulsions

被引:40
作者
Jorgensen, L
Vermehren, C
Bjerregaard, S
Froekjaer, S
机构
[1] Royal Danish Sch Pharm, Dept Pharmaceut, DK-2100 Copenhagen, Denmark
[2] Novo Nordisk AS, Pharmaceut Ge, DK-2820 Gentofte, Denmark
关键词
w/o emulsion; FTIR; insulin growth hormone; secondary structure;
D O I
10.1016/S0378-5173(02)00668-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Water-in-oil (w/o) emulsions have shown a promising release profile of small drug molecules and proteins. However, the major concerns are the structural stability, the retention of the activity and to avoid unwanted immunological reactions caused by the changes in protein structure. In the present study, the secondary structure of insulin and growth hormone is investigated after manufacture of w/o emulsions, using Fourier transform infrared (FTIR) spectroscopy. Initial investigations indicate an altered distribution in the secondary structure elements, e.g. alpha-helix and beta-sheet, measured by area overlap calculations. The changes are more pronounced for growth hormone than for insulin. The overlapping area is 0.93 +/- 0.01 for the emulsion containing insulin manufactured at 0degreesC and homogenised for 3 min, the corresponding value for growth hormone is 0.83 +/- 0.01. The droplet size changes from 0.27 +/- 0.04 mum in the blank w/o emulsion to 0.79 +/- 0.13 and 0.66 +/- 0.21 mum when insulin or growth hormone is incorporated into the w/o emulsions, respectively. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:7 / 10
页数:4
相关论文
共 17 条
[1]   Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions [J].
Bam, NB ;
Cleland, JL ;
Yang, J ;
Manning, MC ;
Carpenter, JF ;
Kelley, RF ;
Randolph, JW .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (12) :1554-1559
[2]  
Baudys M., 2000, PEPTIDE PROTEIN CHAR, P41
[3]   Formulation and evaluation of release and swelling mechanism of a water-in-oil emulsion using factorial design [J].
Bjerregaard, S ;
Söderberg, I ;
Vermehren, C ;
Frokjaer, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 193 (01) :1-11
[4]  
Brange J, 1993, Pharm Biotechnol, V5, P315
[5]  
CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307
[6]  
Cleland JL, 1997, PHARM RES, V14, P4
[7]   PROTEIN SECONDARY STRUCTURES IN WATER FROM 2ND-DERIVATIVE AMIDE-I INFRARED-SPECTRA [J].
DONG, A ;
HUANG, P ;
CAUGHEY, WS .
BIOCHEMISTRY, 1990, 29 (13) :3303-3308
[8]  
Dong AC, 2000, J BIOL CHEM, V275, P27689
[9]   FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres' [J].
Fu, K ;
Griebenow, K ;
Hsieh, L ;
Klibanov, AM ;
Langer, R .
JOURNAL OF CONTROLLED RELEASE, 1999, 58 (03) :357-366
[10]  
HAGENLOCHER M, 1989, PHARMACEUT RES, pS30